Clinical Trial Update: Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the safety and efficacy of abatacept in patients with chronic urticaria who did not respond to antihistamines; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Johns Hopkins University | Conditions: Urticaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-01-25